Business Wire

TX-MARY-KAY

7.10.2020 15:02:09 CEST | Business Wire | Press release

Share
“Guardians of the Gulf” Selected to Premiere at LA Femme International Film Festival This Month

Guardians of the Gulf , an eye-opening documentary that explores the tumultuous relationship between the Gulf of Mexico and the conservationists determined to protect it, has been selected to premiere at the all-digital LA Femme International Film Festival October 15 – 18. Mary Kay Inc., serving as executive producer, with Media One in partnership with The Nature Conservancy, visited the coasts of Texas, Alabama and Mexico to shed light on the often-untold stories of Gulf preservation.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201007005109/en/

Filmed, directed and produced by an all-female crew, Guardians of the Gulf is slated for its global digital premiere on Friday, October 16, 5:00 p.m. PST, with a Q&A including film makers and stars to immediately follow.

Guardians of the Gulf Synopsis:
The Gulf of Mexico has long been impacted by catastrophic natural disasters like hurricanes, overfishing, agricultural run-off and oil spills. However, it continues to support one of the most biodiverse ecosystems on Earth with over 15,000 species. This resilience is tenuous. Like any relationship—only so much can be taken without giving back.

In Guardians of the Gulf , the Gulf of Mexico is given a voice by her caretakers to tell a story of generosity and strength. These conservationists, fisherpeople, tour operators, chefs and student leaders strive to improve sustainability in their work and community. Through action, they see change. Through change, they see hope.

Learn more at https://www.guardiansofthegulf.com .

The LA Femme International Film Festival is a premiere film festival celebrating, supporting and advancing content creation by women producers, writers, and directors from around the world. The festival has advanced the careers of over 1,000 artists and continues to offer educational seminars, programming and networking events in a nurturing indie environment.

Film Credits:
Cait Martin Newnham - Director
Ulla Laidlaw - Director
Aine Corby - Producer
Jenny Williams - Producer
Gayle Ye – Director of Photography
Mary Kay - Executive Producer

Quotes:
“Water isn’t a single issue. It touches every facet of modern life and the only evidence we need for this is the Gulf of Mexico. Where some see its mounting interdependencies as a challenge too great, we see opportunity and a chance to bring more people along with us, as we innovate solutions and change the trajectory for the hardest-working body of water in the world. After watching Guardians of the Gulf , it’s our hope that viewers will have a newfound appreciation for not only the Gulf but the tireless and collaborative efforts being made to sustain it for generations to come.”
Laura Huffman, former Regional Director of The Nature Conservancy in Texas and featured in Guardians of the Gulf

“While learning about the Gulf of Mexico and its recent history, we found ourselves overwhelmed by the depth of its tragedies and their impact. But then we met the incredible people of the Gulf and we quickly acknowledged that a story of hopelessness didn’t fit. We wanted to reflect the strength and resilience of the Gulf in the film’s narrative to give the ecosystem a voice to inspire action and hope.”
Cait Martin Newnham, Director of Guardians of the Gulf

“While we were making Guardians of the Gulf , we fell in love with the Gulf of Mexico. She emerged quickly as a character who is generous, adaptable and powerful. The Gulf gives life and a route for migration to over 15,000 species, and provides humans with food, income and protection from natural disasters. Her reach is far, and her plight is symbolic of the global climate crisis.”
Ulla Laidlaw, Director of Guardians of the Gulf

“One of the most pervasive themes of this documentary is hope. Hope that we are not just maintaining the Gulf of Mexico but how action can result in tangible change. With hope, more people are motivated to take action, and the wave of sustainability continues to swell. The all-female team did an incredible job capturing the dynamism of the Gulf of Mexico. The documentary showcases the people fighting to protect the Gulf and the ability to make change happen. Our hope is Guardians of the Gulf inspires curious minds to learn how they can act locally to impact global sustainability.”
Julia Simon, Chief Legal, Communications and Social Impact Officer for Mary Kay Inc.

About Mary Kay

One of the original glass ceiling breakers, Mary Kay Ash founded her beauty company more than 56 years ago with three goals: develop rewarding opportunities for women, offer irresistible products, and make the world a better place. That dream has blossomed into a multibillion-dollar company with millions of independent sales force members in nearly 40 countries. Mary Kay is dedicated to investing in the science behind beauty and manufacturing cutting-edge skin care, color cosmetics, nutritional supplements and fragrances. Mary Kay is committed to empowering women and their families by partnering with organizations from around the world, focusing on supporting cancer research, protecting survivors from domestic abuse, beautifying our communities, and encouraging children to follow their dreams. Mary Kay Ash’s original vision continues to shine—one lipstick at a time. Learn more at MaryKay.com .

About Media One Creative

Media One is a global creative and production studio specializing in commercial, documentary, and short form content for the brands we love. We pride ourselves on a fully integrated creative and production process which enables us to unite brands with target audiences through authentic storytelling.

Since 2012, we’ve been moving audiences to action with an in-house team of experts in creative development, audio and video production. Learn more at mediaonecreative.ca .

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 19:52:00 CEST | Press release

Jared Genser, one of the world's most recognized international human rights lawyers, and Lanny J. Davis, an adviser to former presidents George W. Bush and Bill Clinton, join the legal and advocacy team for Cambodian businessman Yim Leak and challenge what they call a coordinated smear campaign in Thailand. International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he

Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 17:38:00 CEST | Press release

Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co

Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli® (Relacorilant)18.9.2026 14:00:00 CEST | Press release

Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth

Enhertu® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 14:00:00 CEST | Press release

Recommendation based on DESTINY-Breast05 phase 3 trial results that showed Enhertu reduced the risk of invasive disease recurrence or death by 53% versus T-DM1 Daiichi Sankyo and AstraZeneca’s Enhertu has the potential to become a new standard of care in this early breast cancer setting Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at th

CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 12:58:00 CEST | Press release

The information contained within this press release is for the purpose of scientific exchange.It is intended for scientific, financial and investor media only.If approved, Jyselecawill be indicated for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy.Despite the availability of multiple treatment options, nearly half of people living with axSpA do not respond adequately to current therapies, and just 10-20% reach inactive disease within 16-24 weeks of initiating treatment.CHMP’s positive opinion is based on findings from the OLINGUITO Phase 3 study, where improvements in the signs and symptoms of axSpA with filgotinib were observed early and maintained over 52 weeks of treatment.Jyselecais already approved in Europe and the United Kingdom, for the treatment of moderate to severe rheumatoid arthritis and ulcerative colitis. Alfasigma S.p.A, a global

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye